Evidence map›Paper›PMID 40181967›Full record

ArticleFrontiers in immunology2025

Immunometabolic analysis of primary murine group 2 innate lymphoid cells: a robust step-by-step approach.

Sai Sakktee Krisna, Rebecca C Deagle, Nailya Ismailova, Ademola Esomojumi, Audrey Roy-Dorval, Frederik Roth, Gabriel Berberi, Sonia V Del Rincon, Jörg H Fritz

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sai Sakktee Krisna *Department of Physiology, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Rebecca C Deagle *McGill University Research Centre on Complex Traits (MRCCT), Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Nailya IsmailovaMcGill University Research Centre on Complex Traits (MRCCT), Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Ademola EsomojumiMcGill University Research Centre on Complex Traits (MRCCT), Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Audrey Roy-DorvalMcGill University Research Centre on Complex Traits (MRCCT), Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Frederik RothMcGill University Research Centre on Complex Traits (MRCCT), Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Gabriel BerberiMcGill University Research Centre on Complex Traits (MRCCT), Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Sonia V Del RinconSegal Cancer Centre, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.
Jörg H FritzDepartment of Physiology, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Group 2 Innate Lymphoid Cells (ILC2s) have recently been shown to exert key regulatory functions in both innate and adaptive immune response networks that drive the establishment and progression of type 2 immunity. Although mainly tissue resident, ILC2s and their crosstalk within tissue microenvironments influence metabolism at both the local and systemic levels. In turn, the energetic demand and metabolic status within these systems shape the diverse phenotypes and effector functions of ILC2s. Deciphering these metabolic networks in ILC2s is therefore essential in understanding their various roles in health as well as their associated pathophysiologies. Here we detail a framework of experimental approaches to study key immunometabolic states of primary murine ILC2s and link them to unique phenotypes and their corresponding functionality. Utilizing flow cytometry, Single Cell ENergetic metabolism by profilIng Translation inHibition (SCENITH), and the Seahorse platform we provide a framework that allows in-depth analysis of cellular bioenergetic states to determine the immunometabolic wiring of ILC2s. Connecting immunometabolic states and networks to ILC2 phenotypes and effector functions with this method will allow future in-depth studies to assess the potential of novel pharmaceutics in altering ILC2 functionality in clinical settings.

Indexed as

Energy MetabolismImmunity, InnateLymphocytesAnimalsFlow CytometryMiceMice, Inbred C57BLSingle-Cell Analysisgroup 2 innate lymphoid cells (ILC2)immunometabolismmitochondriaSCENITH (Single Cell ENergetic metabolism by profilIng Translation inhibition)seahorse analysis

Identifiers

PMID40181967
PMCPMC11966487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.